首页 > 最新文献

Hepatobiliary surgery and nutrition最新文献

英文 中文
Laparoscopic duodenum-preserving pancreatic head resection guided by the two-stage indocyanine green fluorescence imaging. 两期吲哚菁绿荧光成像引导下的腹腔镜保十二指肠胰头切除术。
IF 7.8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-01 Epub Date: 2025-09-26 DOI: 10.21037/hbsn-2025-449
Wenjun Lin, Haisu Tao, Jian Yang
{"title":"Laparoscopic duodenum-preserving pancreatic head resection guided by the two-stage indocyanine green fluorescence imaging.","authors":"Wenjun Lin, Haisu Tao, Jian Yang","doi":"10.21037/hbsn-2025-449","DOIUrl":"10.21037/hbsn-2025-449","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"14 5","pages":"902-905"},"PeriodicalIF":7.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12521009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145307861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opportunistic case-finding of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD) by leveraging integrated care pathways of type 2 diabetes. 利用2型糖尿病综合护理途径在代谢功能障碍相关脂肪变性肝病(MASLD)中发现肝纤维化的机会性病例
IF 7.8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-01 Epub Date: 2025-09-26 DOI: 10.21037/hbsn-2025-324
Andrew Makary, Diego Rojo, Laura Pagès, Clara Sabiote, Alba Jiménez-Masip, Juan M Pericàs
{"title":"Opportunistic case-finding of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD) by leveraging integrated care pathways of type 2 diabetes.","authors":"Andrew Makary, Diego Rojo, Laura Pagès, Clara Sabiote, Alba Jiménez-Masip, Juan M Pericàs","doi":"10.21037/hbsn-2025-324","DOIUrl":"10.21037/hbsn-2025-324","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"14 5","pages":"824-828"},"PeriodicalIF":7.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12521010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145307864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating radiomics and 3D bioprinted tumor model: the next-generation approach to improve pancreatic cancer treatment. 整合放射组学和3D生物打印肿瘤模型:改善胰腺癌治疗的新一代方法。
IF 7.8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-01 Epub Date: 2025-09-23 DOI: 10.21037/hbsn-2025-676
Wei Liu, Huayu Yang, Zhengrong Zhou
{"title":"Integrating radiomics and 3D bioprinted tumor model: the next-generation approach to improve pancreatic cancer treatment.","authors":"Wei Liu, Huayu Yang, Zhengrong Zhou","doi":"10.21037/hbsn-2025-676","DOIUrl":"10.21037/hbsn-2025-676","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"14 5","pages":"874-877"},"PeriodicalIF":7.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12521031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145307923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing surgical techniques: a first application of remote robotic pancreaticoduodenectomy for resectable malignant tumor. 外科技术的进步:远程机器人胰十二指肠切除术在可切除恶性肿瘤中的首次应用。
IF 7.8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-01 Epub Date: 2025-07-24 DOI: 10.21037/hbsn-2025-306
Wen-Bo Zou, Zhao-Ping Wu, Wei-Li Chen, Ning-Bo Fang, Jian Yang, Guo-Dong Zhao
{"title":"Advancing surgical techniques: a first application of remote robotic pancreaticoduodenectomy for resectable malignant tumor.","authors":"Wen-Bo Zou, Zhao-Ping Wu, Wei-Li Chen, Ning-Bo Fang, Jian Yang, Guo-Dong Zhao","doi":"10.21037/hbsn-2025-306","DOIUrl":"10.21037/hbsn-2025-306","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"14 4","pages":"662-664"},"PeriodicalIF":7.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12393110/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144951717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quest for an accurate and reproducible prognostic biomarker of severe acute pancreatitis: have we finally found it? 寻找一种准确和可重复的严重急性胰腺炎预后生物标志物:我们最终找到了吗?
IF 7.8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-01 Epub Date: 2025-07-25 DOI: 10.21037/hbsn-2025-159
Peter J Lee, Fred S Gorelick, Georgios I Papachristou
{"title":"Quest for an accurate and reproducible prognostic biomarker of severe acute pancreatitis: have we finally found it?","authors":"Peter J Lee, Fred S Gorelick, Georgios I Papachristou","doi":"10.21037/hbsn-2025-159","DOIUrl":"10.21037/hbsn-2025-159","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"14 4","pages":"639-642"},"PeriodicalIF":7.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12393122/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144951519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The risk of hepatocellular carcinoma recurrence after liver transplantation increases with locoregional therapies in patients initially within Milan criteria. 在最初符合米兰标准的患者中,肝移植后肝细胞癌复发的风险随着局部治疗而增加。
IF 7.8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-01 Epub Date: 2024-09-05 DOI: 10.21037/hbsn-24-107
Jinsoo Rhu, Namkee Oh, Gyu-Seong Choi, Jongman Kim, Jae-Won Joh

Background: The optimal timing of transplantation for hepatocellular carcinoma (HCC) is still under debate regarding the tumor biology and locoregional control with various treatments. We designed this study to find out what kind of factors affect the post-transplantation outcome focusing on the timing of transplantation.

Methods: We analyzed HCC patients who met the Milan criteria at the initial stage and subsequently underwent liver transplantation (LT) between 2007 and 2020. We examined the number of locoregional therapies (LRTs) received, as well as data on tumor recurrence and survival. The number of LRTs was categorized into four groups: none, one or two, three or four, and five or more. Both recurrence-free survival and overall survival were analyzed.

Results: A total of 423 patients who met the Milan criteria at the initial stage underwent LT. The median number of LRTs before transplantation was 2, with an interquartile range of 0 to 4. There were 112 patients (26.5%) who underwent LT as the initial treatment. Multivariable Cox analyses showed that the number of LRTs [hazard ratio (HR) =1.219, 95% confidence interval (CI): 1.074-1.382, P=0.002] was a significant factor for recurrence. When analyzed as a categorical variable, three or four LRTs (HR =4.936, 95% CI: 1.790-13.615, P=0.002) and five or more LRTs (HR =5.129, 95% CI: 1.958-13.440, P=0.001) showed a significantly higher risk compared to the primary transplantation group.Conclusions: This study showed that the risk of recurrence after transplantation increases with the increasing number of LRTs prior to LT. Therefore, optimal timing of LT should be cautiously decided in regards of recurrence potential of each patient.

背景:肝细胞癌(HCC)的最佳移植时机仍然存在争议,包括肿瘤生物学和不同治疗方法的局部控制。我们设计这项研究是为了找出哪些因素影响移植后的结果,重点是移植的时机。方法:我们分析了2007年至2020年间在初始阶段符合米兰标准并随后接受肝移植(LT)的HCC患者。我们检查了接受的局部区域治疗(LRTs)的数量,以及肿瘤复发和生存的数据。轻轨车的数量分为4组:没有、1 ~ 2辆、3 ~ 4辆、5辆以上。分析无复发生存期和总生存期。结果:共有423例初始阶段符合米兰标准的患者接受了lrt。移植前lrt的中位数为2例,四分位数范围为0 ~ 4。有112例(26.5%)患者接受了肝移植作为初始治疗。多变量Cox分析显示,LRTs数量[危险比(HR) =1.219, 95%可信区间(CI): 1.074 ~ 1.382, P=0.002]是复发的重要因素。当作为一个分类变量进行分析时,3个或4个lrt (HR =4.936, 95% CI: 1.790-13.615, P=0.002)和5个或更多lrt (HR =5.129, 95% CI: 1.958-13.440, P=0.001)与初次移植组相比显示出显著更高的风险。结论:本研究显示,移植后复发的风险随着移植前lrt数量的增加而增加。因此,移植的最佳时机应根据每个患者的复发可能性谨慎决定。
{"title":"The risk of hepatocellular carcinoma recurrence after liver transplantation increases with locoregional therapies in patients initially within Milan criteria.","authors":"Jinsoo Rhu, Namkee Oh, Gyu-Seong Choi, Jongman Kim, Jae-Won Joh","doi":"10.21037/hbsn-24-107","DOIUrl":"10.21037/hbsn-24-107","url":null,"abstract":"<p><strong>Background: </strong>The optimal timing of transplantation for hepatocellular carcinoma (HCC) is still under debate regarding the tumor biology and locoregional control with various treatments. We designed this study to find out what kind of factors affect the post-transplantation outcome focusing on the timing of transplantation.</p><p><strong>Methods: </strong>We analyzed HCC patients who met the Milan criteria at the initial stage and subsequently underwent liver transplantation (LT) between 2007 and 2020. We examined the number of locoregional therapies (LRTs) received, as well as data on tumor recurrence and survival. The number of LRTs was categorized into four groups: none, one or two, three or four, and five or more. Both recurrence-free survival and overall survival were analyzed.</p><p><strong>Results: </strong>A total of 423 patients who met the Milan criteria at the initial stage underwent LT. The median number of LRTs before transplantation was 2, with an interquartile range of 0 to 4. There were 112 patients (26.5%) who underwent LT as the initial treatment. Multivariable Cox analyses showed that the number of LRTs [hazard ratio (HR) =1.219, 95% confidence interval (CI): 1.074-1.382, P=0.002] was a significant factor for recurrence. When analyzed as a categorical variable, three or four LRTs (HR =4.936, 95% CI: 1.790-13.615, P=0.002) and five or more LRTs (HR =5.129, 95% CI: 1.958-13.440, P=0.001) showed a significantly higher risk compared to the primary transplantation group.<b>Conclusions:</b> This study showed that the risk of recurrence after transplantation increases with the increasing number of LRTs prior to LT. Therefore, optimal timing of LT should be cautiously decided in regards of recurrence potential of each patient.</p>","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"14 4","pages":"539-551"},"PeriodicalIF":7.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12393127/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144951734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Auxiliary liver transplantation using otherwise-discarded liver allograft combined with associating liver partition and portal vein ligation for staged hepatectomy for unresectable colorectal liver metastases. 对不可切除的结直肠癌肝转移灶,采用非切除的同种异体肝脏辅助肝移植联合相关肝分区和门静脉结扎进行分期肝切除术。
IF 7.8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-01 Epub Date: 2025-06-25 DOI: 10.21037/hbsn-2025-392
Zheng Wang, Xiaowu Huang, Yinghong Shi, Xiaoying Wang, Zhenbin Ding, Yongsheng Xiao, Yifeng He, Ting Wang, Jian Sun, Kang Song, Zaozhuo Shen, Lei Yu, Kai Zhu, Changhong Miao, Yuan Ji, Liuxiao Yang, Yingyong Hou, Qiang Gao, Jia Fan, Jian Zhou
{"title":"Auxiliary liver transplantation using otherwise-discarded liver allograft combined with associating liver partition and portal vein ligation for staged hepatectomy for unresectable colorectal liver metastases.","authors":"Zheng Wang, Xiaowu Huang, Yinghong Shi, Xiaoying Wang, Zhenbin Ding, Yongsheng Xiao, Yifeng He, Ting Wang, Jian Sun, Kang Song, Zaozhuo Shen, Lei Yu, Kai Zhu, Changhong Miao, Yuan Ji, Liuxiao Yang, Yingyong Hou, Qiang Gao, Jia Fan, Jian Zhou","doi":"10.21037/hbsn-2025-392","DOIUrl":"10.21037/hbsn-2025-392","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"14 4","pages":"683-688"},"PeriodicalIF":7.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12393113/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144951768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Call a spade a spade. 有话直说。
IF 7.8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-01 Epub Date: 2025-07-24 DOI: 10.21037/hbsn-2025-352
Elke Roeb
{"title":"Call a spade a spade.","authors":"Elke Roeb","doi":"10.21037/hbsn-2025-352","DOIUrl":"10.21037/hbsn-2025-352","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"14 4","pages":"712-715"},"PeriodicalIF":7.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12393097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144951742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empagliflozin for non-diabetic metabolic dysfunction-associated steatotic liver disease: a promising therapeutic agent in transition. 恩格列净治疗非糖尿病性代谢功能障碍相关的脂肪变性肝病:一种有前景的过渡性治疗药物
IF 7.8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-01 Epub Date: 2025-07-25 DOI: 10.21037/hbsn-2025-250
Mohamed El-Kassas, Hongqun Liu, Samuel S Lee
{"title":"Empagliflozin for non-diabetic metabolic dysfunction-associated steatotic liver disease: a promising therapeutic agent in transition.","authors":"Mohamed El-Kassas, Hongqun Liu, Samuel S Lee","doi":"10.21037/hbsn-2025-250","DOIUrl":"10.21037/hbsn-2025-250","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"14 4","pages":"651-654"},"PeriodicalIF":7.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12393100/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144951787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing a new source for organ transplantation. 开发器官移植的新来源。
IF 7.8 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-08-01 Epub Date: 2025-06-30 DOI: 10.21037/hbsn-2025-445
Shunda Du, Yilei Mao
{"title":"Developing a new source for organ transplantation.","authors":"Shunda Du, Yilei Mao","doi":"10.21037/hbsn-2025-445","DOIUrl":"10.21037/hbsn-2025-445","url":null,"abstract":"","PeriodicalId":12878,"journal":{"name":"Hepatobiliary surgery and nutrition","volume":"14 4","pages":"709-711"},"PeriodicalIF":7.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12393099/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144951862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hepatobiliary surgery and nutrition
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1